NCT05917587View on ClinicalTrials.gov

Metformin for the Treatment of Microvascular Dysfunction After Gestational Diabetes

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

September 11, 2024

Primary Completion Date

December 31, 2027

Study Completion Date

June 30, 2028

Conditions
Gestational Diabetes
Interventions
DRUG

Metformin Hydrochloride

12 weeks: 850mg metformin once daily for first 7 days then twice daily for the remaining 11 weeks.

OTHER

placebo

12 weeks: placebo tablet once daily for the first 7 days then twice daily for the remaining 11 weeks.

Trial Locations (1)

52242

RECRUITING

University of Iowa, Iowa City

All Listed Sponsors
lead

Anna Stanhewicz, PhD

OTHER